Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

filter by theme
Women's health
Endocrinology
Academic support
Non clinical
 contact us

Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

Levonorgestrel-only emergency contraception: real-world tolerance and efficacy.
Gainer E, Méry C, Ulmann A.Contraception. 2001 Jul;64(1):17-21.
Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception.
Gainer E, Massai R, Lillo S, Reyes V, Forcelledo ML, Caviedes R, Villarroel C, Bouyer J.Hum Reprod. 2007 Jun;22(6):1578-84.
Linkage and mutational analysis of familial thyroid dysgenesis demonstrate genetic heterogeneity implicating novel genes.
Castanet M, Sura-Trueba S, Chauty A, Carré A, de Roux N, Heath S, Léger J, Lyonnet S, Czernichow P, Polak M.Eur J Hum Genet. 2005 Feb;13(2):232-9.
M909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins
Isabelle Petit-Topin, Nathalie Turque, Jérôme Fagart, André Ulmann, Erin Gainer and Marie-Edith Rafestin-OblinMol Pharmacol. Mol Pharmacol. 2009 Jun;75(6):1317-24. Epub 2009 Mar 16.
Menstrual bleeding patterns following levonorgestrel emergency contraception.
Gainer E, Kenfack B, Mboudou E, Doh AS, Bouyer J.Contraception. 2006 Aug;74(2):118-24.
Misoprostol: Why Gymiso?
Ulmann A.Gynecol Obstet Fertil. 2006 Oct;34(10):883-4.
Molecular mechanisms of thyroid dysgenesis.
Polak M, Sura-Trueba S, Chauty A, Szinnai G, Carré A, Castanet M.Horm Res. 2004;62 Suppl 3:14-21. Review.
Pharmacologic properties of CDB(VA)-2914.
Gainer EE, Ulmann A.Steroids. 2003 Nov;68(10-13):1005-11.
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?